|
Session 183-Poster Abstracts
ART Pharmacokinetics and Safety during Pregnancy and Breastfeeding
Friday, 2-4 pm; Poster Hall |
906
 |
Pharmacokinetics of Lopinavir Boosted with Ritonavir Initiated during the Third Trimester of Pregnancy in HIV-1-infected Thai Women
Tim Cressey*1,2, G Jourdain1,2, B Rawangban3, P Yuthavisuthi4, S Varadisai5, R Kongpanichkul6, P Sabsanong7, N Ngo-Giang-Huong1,2, S Pattarakulwanich8, M Lallemant1,2, and the PHPT-5 Study Team
1Faculty of Associated Med Sci, Chiang Mai Univ, Thailand; 2Harvard Sch of Publ Hlth, Boston, MA, US; 3Nopparat Rajathanee Hosp, Bangkok, Thailand; 4Prapokklao Hosp, Chantaburi, Thailand; 5Samutsakhon Hosp, Thailand; 6Nakhonpathom Hosp, Thailand; 7Samutprakarn Hosp, Thailand; and 8Ministry of Publ Hlth, Nonthaburi, Thailand |
907
|
Steady State Pharmacokinetic of Ritonavir-boosted Atazanavir in 31 Pregnant Women before and after Delivery
D Ripamonti1, D Cattaneo2, A d’Avolio3, M Simiele3, S Bonora3, N Strobelt1, M Ruggeri1, E Bombana1, F Maggiolo1, and Fredy Suter*1
1Hosp Riuniti de Bergamo, Italy; 2Hosp Luigi Sacco, Milan, Italy; and 3Hosp A di Savoia, Turin, Italy |
| 908 |
Boosted Fosamprenavir Pharmacokinetics during Pregnancy
Edmund Capparelli*1, A Stek2, B Best1, S Rossi1, S Burchett3, H Li4, J Read5, E Smith6, E Hawkins7, M Mirochnick8, and IMPAACT P1026S Team
1Univ of California, San Diego, US; 2Univ of Southern California, Los Angeles, US; 3Children’s Hosp Boston, MA, US; 4Harvard Sch of Publ Hlth, Boston, MA, US; 5Natl Inst of Child Hlth and Human Devt, NIH, Bethesda, MD, US; 6NIAID, NIH, Bethesda, MD, US; 7IMPAACT Operations Office; and 8Boston Univ, MA, US |
909
|
Tolerance and Viral Resistance after sdNVP and Short-course TDF/FTC in Delivering Women and Neonates to Prevent MTCT of HIV-1: The TEmAA ANRS 12109 Trial, Step 2
Elise Arrivé*1, M-L Chaix2, E Nerrienet3, S Blanche2, C Rouzioux2, D Avit4, M Nyati5, S Kruy Leang6, D Ekouévi4, F Dabis1, and TEmAA ANRS 12109 Study Group
1INSERM U897, ISPED, Univ Victor Segalen Bordeaux, France; 2Hosp Necker Enfants Malades, Univ Paris Descartes, France; 3Inst Pasteur, Phnom Penh, Cambodia; 4Prgm PACCI, ANRS, Abidjan, Côte d’Ivoire; 5Univ of the Witwatersrand, Soweto, South Africa; and 6Hosp Calmette, Phnom Penh, Cambodia |
910
|
Impact of Systemic and Mucosal NVP Levels on Serial HIV RNA Levels in Maternal Plasma and Breast Milk after Perinatal sdNVP
Jim Aizire*1, P Mudiope1, F Matovu1, M Mubiru1, A Elbireer1, E Janoff2, and M G Fowler3
1Makerere Univ-Johns Hopkins Univ Res Collaboration, Kampala, Uganda; 2Univ of Colorado Denver and Hlth Sci Ctr, US; and 3Johns Hopkins Univ Sch of Med, Baltimore, MD, US |
| 911 |
Population Pharmacokinetics of Nevirapine in HIV-1-infected Pregnant Women and Their Neonates: TEmAA ANRS 12109
S Benaboud1, D Ekouevi2, S Urien3, E Rey3, E Arrivé4, S Blanche1,5, G Gray6, K Leang Sim7, Jean-Marc Treluyer*1,3, D Hirt1, and TEmAA ANRS 12109 Study Group
1Univ Paris Descartes, Paris, France; 2ANRS, Abidjan, Côte d’Ivoire; 3Cochin Saint Vincent de Paul Hosp, AP-HP, Paris, France; 4Univ Victor Segalen Bordeaux, France; 5Hosp Necker, Paris, France; 6Univ of the Witwatersrand, Soweto, South Africa; and 7Hosp Calmette, Phnom Penh, Cambodia |
|
